药物基因组学

Pharmacogenomics helps us understand how genetic differences can affect an individual's response to medication.
药物基因组学帮助我们理解基因差异如何影响个体对药物的反应。
Pharmacogenomics allows for the development of personalized medicine, tailoring treatments based on a patient's specific genetic makeup.
药物基因组学使得个性化药物得以发展，基于患者的特定基因构成制定治疗方案。
The field of pharmacogenomics aims to predict which drugs will be most effective and least harmful for each patient.
药物基因组学领域旨在预测哪种药物对每位患者最有效且副作用最小。
By studying pharmacogenomics, doctors can identify patients who may have adverse reactions to certain medications before prescribing them.
通过研究药物基因组学，医生可以在开药前识别出可能对某些药物有不良反应的患者。
Advances in pharmacogenomics have led to the creation of targeted therapies for cancer treatment, designed to exploit specific genetic mutations in tumors.
药物基因组学的进步已促成了针对癌症治疗的靶向疗法的产生，这些疗法旨在利用肿瘤中的特定基因突变。
Pharmacogenomics plays a crucial role in understanding drug metabolism and predicting drug-drug interactions.
药物基因组学在理解药物代谢和预测药物相互作用中起着至关重要的作用。
A key application of pharmacogenomics is in identifying genetic biomarkers that can predict therapeutic outcomes or guide dosage adjustments.
药物基因组学的一个关键应用是识别能够预测治疗结果或指导剂量调整的遗传生物标志物。
Through pharmacogenomic testing, clinicians can optimize drug selection and dosing to minimize side effects and maximize therapeutic benefits.
通过药物基因组测试，临床医师可以优化药物选择和剂量以尽量减少副作用并最大限度地提高治疗效果。
The integration of pharmacogenomics into clinical practice has the potential to significantly improve healthcare quality and reduce unnecessary healthcare costs.
将药物基因组学融入临床实践有可能显著提高医疗服务质量并降低不必要的医疗成本。
Pharmacogenomics offers promise for future healthcare by enabling the development of safer, more effective medications tailored to an individual’s genetic profile.
药物基因组学通过对个体基因特征进行定制，为未来的医疗保健提供了开发更安全、更有效的药物的可能性。